文献速递头颈外科咽喉与嗓音

经口机器人手术治疗口咽癌后吞咽困难与口干结局评估

Evaluating dysphagia and xerostomia outcomes following transoral robotic surgery for patients with oropharyngeal cancer.
PubMed 文献 · Head Neck · 2021-10-07

本研究通过横断面调查评估了口咽癌患者接受经口机器人手术(TORS)作为根治性治疗后的长期吞咽困难和口干结局。研究纳入62例患者,比较了TORS单独(TORS-A)、TORS联合放疗(TORS+RT)及联合放化疗(TORS+CT/RT)三组的MDADI和XI评分。结果显示TORS-A组的吞咽困难及口干评分均显著优于辅助治疗组。

要点

  • TORS-A组MDADI评分显著优于TORS+RT(p=0.03)和TORS+CT/RT(p=0.02)。
  • TORS-A组XI评分显著低于TORS+RT(p<0.01)和TORS+CT/RT(p<0.01)。
  • TORS+RT与TORS+CT/RT两组间MDADI评分无显著差异。

核心结论

  • 接受TORS+RT或TORS+CT/RT的口咽癌患者术后吞咽困难和口干结局在临床上差于仅接受TORS-A的患者。

研究设计与样本

  • 横断面调查研究,纳入2015年至2019年间以原发性口咽手术为根治性治疗且至少1年前治疗的口咽癌患者62例(TORS-A 10例,TORS+RT 30例,TORS+CT/RT 22例)。

主要发现

  • TORS-A组MDADI评分在临床和统计学上均显著优于TORS+RT组(p=0.03)和TORS+CT/RT组(p=0.02)。
  • TORS+RT组与TORS+CT/RT组之间MDADI评分无显著差异。
  • TORS-A组XI评分在临床和统计学上均显著低于TORS+RT组(p<0.01)和TORS+CT/RT组(p<0.01)。

关键数值与推荐

  • MDADI评分比较:TORS-A vs TORS+RT p=0.03;TORS-A vs TORS+CT/RT p=0.02。
  • XI评分比较:TORS-A vs TORS+RT p<0.01;TORS-A vs TORS+CT/RT p<0.01。

临床怎么用

  • 对于接受TORS的口咽癌患者,应关注辅助放疗或放化疗对长期吞咽功能和口干的负面影响。
  • 在制定治疗策略时,需权衡辅助治疗的必要性与患者报告结局的潜在恶化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We assessed long-term patient-reported dysphagia and xerostomia outcomes following definitive surgical management with transoral robotic surgery (TORS) in patients with oropharyngeal cancer (OPC) via a cross-sectional survey study. METHODS: Patients with OPC managed with primary oropharyngeal surgery as definitive treatment at least 1 year ago between 2015 and 2019 were identified. The M. D. Anderson Dysphagia Inventory (MDADI) and Xerostomia Inventory (XI) scores were compared across treatment types (i.e., no adjuvant therapy [TORS-A] vs. adjuvant radiotherapy [TORS+RT] vs. adjuvant chemoradiotherapy [TORS+CT/RT]). RESULTS: The sample had 62 patients (10 TORS-A, 30 TORS+RT, 22 TORS+CT/RT). TORS-A had clinically and statistically significantly better MDADI scores than TORS+RT (p = 0.03) and TORS+CT/RT (p = 0.02), but TORS+RT and TORS+CT/RT were not significantly different. TORS-A had clinically and statistically significantly less XI than TORS+RT (p < 0.01) and TORS+CT/RT (p < 0.01). CONCLUSIONS: Patients with OPC who have undergone TORS+RT or TORS+CT/RT following surgery face clinically worse dysphagia and xerostomia outcomes relative to patients who undergo TORS-A.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Mehta MP, Prince R, Butt Z, et al. Evaluating dysphagia and xerostomia outcomes following transoral robotic surgery for patients with oropharyngeal cancer. Head Neck. 2021. PMID: 34617643. doi:10.1002/hed.26887

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。